Cara Therapeutics
(NASDAQ:CARA)
$12.77
0.81[6.77%]
At close: Dec 2(Delayed 15-Minutes)
Get Real Time Here
$12.64
-0.1300[-1.02%]
After Hours: 6:48PM EDT
Day Range11.6 - 12.8152 Wk Range7.4 - 13.97Open / Close11.74 / 12.77Float / Outstanding37.9M / 53.7M
Vol / Avg.390.7K / 340.8KMkt Cap686.2MP/E-50d Avg. Price9.98
Div / Yield-Payout Ratio-Total Float37.9MEPS-0.43

Cara Therapeutics Stock (NASDAQ:CARA), Quotes and News Summary

Cara Therapeutics Stock (NASDAQ: CARA) stock price, news, charts, stock research, profile.

Loading...
Day Range11.6 - 12.8152 Wk Range7.4 - 13.97Open / Close11.74 / 12.77Float / Outstanding37.9M / 53.7M
Vol / Avg.390.7K / 340.8KMkt Cap686.2MP/E-50d Avg. Price9.98
Div / Yield-Payout Ratio-Total Float37.9MEPS-0.43
Seeking Alpha - Nov 26, 2022, 1:32AM
Seeking Alpha - Nov 7, 2022, 12:30AM
InvestorsObserver - Aug 9, 2022, 3:18PM
Sector: Health Care.Industry: Pharmaceuticals
Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-28
REV
Q3 2022Est.ActualSurprise
EPS-0.420-0.430 -0.0100
REV9.830M10.813M983.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Cara Therapeutics (CARA) stock?

A

You can purchase shares of Cara Therapeutics (NASDAQ: CARA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Cara Therapeutics's (CARA) competitors?

Q

What is the target price for Cara Therapeutics (CARA) stock?

A

The latest price target for Cara Therapeutics (NASDAQ: CARA) was reported by Canaccord Genuity on Monday, March 14, 2022. The analyst firm set a price target for 29.00 expecting CARA to rise to within 12 months (a possible 127.09% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Cara Therapeutics (CARA)?

A

The stock price for Cara Therapeutics (NASDAQ: CARA) is $12.77 last updated December 2, 2022, 9:00 PM UTC.

Q

Does Cara Therapeutics (CARA) pay a dividend?

A

There are no upcoming dividends for Cara Therapeutics.

Q

When is Cara Therapeutics (NASDAQ:CARA) reporting earnings?

A

Cara Therapeutics’s Q4 earnings are confirmed for Tuesday, February 28, 2023.

Q

Is Cara Therapeutics (CARA) going to split?

A

There is no upcoming split for Cara Therapeutics.

Q

What sector and industry does Cara Therapeutics (CARA) operate in?

A

Cara Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.